Abstract
Purpose To determine the structural characteristics of the peripapillary sclera in myopic eyes using polarization-sensitive optical coherence tomography (PS-OCT).
Methods Patients with myopia who underwent PS-OCT imaging between April and June 2023 were studied. The intensity, optic axis, and birefringence of PS-OCT images were analyzed to determine the surface of the lamina cribrosa (LC). The direction and arrangement of the scleral collagen fibers in the peripapillary region and scleral ridge were determined.
Results One hundred and ten eyes of 59 patients with myopia (mean axial length, 30.00 ± 1.98 mm) were studied. The scleral fibers around the optic nerve were arranged circularly in all eyes regardless of the presence or size of the peripapillary atrophy. Inner scleral fibers that penetrated beneath this circular arrangement were detected in 98 eyes (89.1%). There was a Y-shaped split at the point of penetration in 77 eyes (70.0%). The integrity of the circular arrangement and penetrating scleral fiber complexes remained intact even in cases of severe peripapillary scleral deformation. A scleral ridge was identified in 27 eyes (24.5%), and it appeared as a full-thickness protrusion composed primarily of outer scleral fibers. The ridge was consistently located outside the circular arrangement.
Conclusions The penetration of the radial inner scleral fibers into the circular arrangement and extension to the LC suggest that they act as stabilizing anchors for the circular structure. The differences of the scleral ridges from those in eyes with dome-shaped macula suggest that unique mechanisms cause the scleral differences.
Competing Interest Statement
Dr Xiong reported receiving a research grant from JST SPRING. Dr Ohno-Matsui reported receiving a research grant from Tomey Corporation and being a consultant for Santen and Cooper Vision outside the submitted work. Dr Yamanari reported having patents for JP 6463051 B2, US 9593936 B2, EP 2995245 B1, JP 6542178 B2, and JP 7332131 B2 issued to Tomey Corporation. Dr Yoshida belongs to the Department of Advanced Ophthalmic Imaging at the Institute of Science Tokyo, which is funded by NIDEK Corporation. No other disclosures were reported.
Funding Statement
This work was supported by JST SPRING, Grant Number JPMJSP2120, and received partial research funding from Tomey Corporation. The funding organization and Tomey Corporation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Institute of Science Tokyo gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding/Support This work was supported by JST SPRING, Grant Number JPMJSP2120, and received partial research funding from Tomey Corporation. The funding organization and Tomey Corporation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Conflict of Interest/Financial Disclosures Dr Xiong reported receiving a research grant from JST SPRING. Dr Ohno-Matsui reported receiving a research grant from Tomey Corporation and being a consultant for Santen and Cooper Vision outside the submitted work. Dr Yamanari reported having patents for JP 6463051 B2, US 9593936 B2, EP 2995245 B1, JP 6542178 B2, and JP 7332131 B2 issued to Tomey Corporation. Dr Yoshida belongs to the Department of Advanced Ophthalmic Imaging at the Institute of Science Tokyo, which is funded by NIDEK Corporation. No other disclosures were reported.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
